Digital Tools for Detecting and Monitoring Parkinson's Disease
Collects eye movement and gait data from people with Parkinson's to build diagnostic tools.
Plain-language title generated from the registry record
Registry title: Development of Digital Services for Parkinson's Disease
Key facts
- Where
- Exeter, United KingdomSee the site
Where in United Kingdom
- University Of ExeterExeter, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Exeter
- Trial code
- NCT06733077
- Record updated
- 3 February 2025
- Original description
In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.Read full original descriptionShow less
Development of Digital Diagnostics and Intervention Services for Parkinson's Disease
In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.
Inclusion: Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition specific scale [stroke, multiple sclerosis, arthritis or osteoporosis]; Able to self-report history of daily gait freezing and/or festination for people with PD or gait and/or transfers affected by condition; Able to walk unsupported or using an aid for at least 5 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise; Adult (+18 years old); Normal or corrected-to-normal vision (Snellen Visual Acuity > 12/18) or safe to mobilise with support; Montreal Cognitive assessment score >21 or ability to follow 2 stage commands; Healthy participants [Phase 1,2,3]; With no long-term conditions affecting movement; Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise; Adult (+18 years old); Normal or corrected-to-normal vision (Snellen Visual Acuity > 12/18) or safe to mobilise with support; Montreal Cognitive assessment score >21 or ability to follow 2 stage commands.
Exclusion: Deep brain stimulation or pacemaker implants or other implant that may interfere with the measurement system; Medications likely to affect eye sight or use of virtual reality sytstem; Healthy participants; Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system; Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team; Cognitive impairment affecting ability to safely participate and follow instructions; Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition); Any skin conditions or broken skin in the calf and behind knee area; Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team; Cognitive impairment affecting ability to safely participate and follow instructions; Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition); Any skin conditions or broken skin in the calf and behind knee area.